Dan Abrams is the founder of Cerebral Therapeutics. Cerebral Therapeutics has raised $78M in total funding. Latest round: Series C. Based in Aurora, Colorado.
Dan Abrams, M.D., is a physician executive and neuroscience leader who founded Cerebral Therapeutics, a clinical-stage pharmaceutical company focused on severe refractory epilepsy and neurological diseases. Under his leadership, the company progressed from concept and early clinical data to Series C (Phase 2b), raising over $70 million primarily from institutional biotech investors.
Full founder directory · Investor directory · Company funding database · Fundraising library